Estimates Revisions Sionna Therapeutics, Inc.
Stocks
SION
US8294011080
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 7.850 USD | +3.02% |
|
+9.33% | -80.92% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | BTIG Downgrades Sionna Therapeutics to Neutral From Buy | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- SION Stock
- Consensus Sionna Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
